| |
| |
|
| Insider
Information: |
Matsui Connie |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
273,009 |
|
|
Indirect Shares
|
40,766 |
|
|
| Direct
Value |
$15,267,159 |
|
|
|
Indirect Value
|
$9,457,304 |
|
|
| Total
Shares |
313,775 |
|
|
| Total
Value |
$24,724,463 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -16.5%
|
 66.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Corp. Strategy an... |
2007-02-12 |
22,837 |
2007-02-12 |
40,766 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
193,505 |
|
0 |
Premium* |
|
|
Artelo Biosciences, Inc. |
ARTL |
|
2020-05-04 |
56,667 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Sr V P, Planning& Resource Dev |
• – – |
2003-11-19 |
4 |
OE |
$3.50 |
$216,766 |
D/D |
40,000 |
187,371 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2024-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,501 |
193,505 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-09-14 |
4 |
OE |
$2.33 |
$72,700 |
D/D |
20,000 |
203,051 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,000 |
208,753 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
213,983 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-09-11 |
4 |
S |
$27.06 |
$865,792 |
D/D |
(32,000) |
216,753 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2016-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,202 |
223,253 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2018-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
227,751 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-05-18 |
4/A |
OE |
$6.92 |
$415,002 |
D/D |
60,000 |
230,274 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2017-09-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
232,388 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,135 |
237,388 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
239,924 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,363 |
242,751 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2017-05-08 |
4 |
OE |
$10.37 |
$103,700 |
D/D |
10,000 |
247,388 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
248,753 |
0 |
- |
|
65 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
